SXTC
NASDAQ · Pharmaceuticals
China Sxt Pharmaceuticals In
$2.41
+0.03 (+1.26%)
Open$2.33
Previous Close$2.38
Day High$2.43
Day Low$2.30
52W High$83,758.40
52W Low—
Volume—
Avg Volume1.52M
Market Cap2.89M
P/E Ratio—
EPS$-7.95
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.02M | 2.42M | 998.7K |
| Net Income | -11,007,678 | -11,895,905 | 158.4K |
| Profit Margin | -545.2% | -518.0% | 15.9% |
| EBITDA | -12,515,630 | -14,276,955 | 317.7K |
| Free Cash Flow | — | — | 143.5K |
| Rev Growth | -16.7% | -16.7% | +6.7% |
| Debt/Equity | 0.03 | 0.03 | 0.71 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,168.88 | +0.34% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.65 | +0.07% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $151.72 | +1.48% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.87 | +0.47% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.62 | -0.70% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $73.00 | +2.34% | 11.5 | 30.15B |